Filing Flows › Axogen (AXGN) › R&D spending
Axogen (AXGN) R&D spending by quarter
Axogen's R&D spending was $8.9M in Q3 2026 (third quarter 2026), +4% from Q2 2026. Over the last 7 quarters it ranged from $6.1M (Q1 2025) to $12.4M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $8.9M | +4% | +18% |
| Q2 2026 | $8.6M | +14% | +25% |
| Q1 2026 | $7.5M | -39% | +23% |
| Q4 2025 | $12.4M | +64% | — |
| Q3 2025 | $7.6M | +10% | — |
| Q2 2025 | $6.9M | +13% | — |
| Q1 2025 | $6.1M | — | — |
Q3 2026 at a glance
Axogen, Q3 2026: revenue $75.8M (+26% year over year), operating margin 1.3%, net earnings $2.3M, operating cash flow $16.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Axogen's R&D spending?
Axogen's R&D spending was $8.9M in Q3 2026 (third quarter 2026), +4% from Q2 2026.
How has Axogen's R&D spending changed?
Over the last 7 quarters it ranged from $6.1M (Q1 2025) to $12.4M (Q4 2025).